Every sales manager has felt the sting of a "sure thing" deal falling through at the last minute. You look at your HubSpot pipeline and see a $50,000 deal sitting in the "Negotiation" stage. The close date is tomorrow. You have already factored it into your monthly forecast. Then, the prospect goes dark.
This happens because deal stage and deal health are not the same thing. A deal can be in a late stage but still be "unhealthy" and unlikely to close. Understanding the difference is the key to accurate forecasting and hitting your targets.
What is HubSpot deal health?
Deal health is a measure of how likely a deal is to close based on real-time activity and historical patterns. While a deal stage tells you where a prospect is in your process, deal health tells you if they are actually moving forward.
Healthy deals move through stages at a consistent pace. They have regular communication between the rep and the prospect. They involve the right decision-makers. When a deal is healthy, your forecast is reliable.
Ignoring at-risk deals is expensive. It wastes your sales team's time on opportunities that will never convert. It also creates a "bloated" pipeline that gives you a false sense of security. By identifying health signals early, you can either course-correct or stop wasting resources on "zombie" deals.
7 signals your HubSpot deal is at risk
Identifying a failing deal early allows you to step in and help your team. Here are seven common signals that a deal in your HubSpot CRM is in trouble.
1. Stalled stage velocity
Every sales process has a natural rhythm. If your average deal spends 10 days in the "Discovery" stage, a deal that has been there for 30 days is a red flag. Stalled velocity usually means the prospect has lost interest or a competitor has entered the picture. Research by A. Kumar et al. (2026) shows that adaptive machine learning models can identify these "similarity of outcomes" patterns much faster than a human manager reviewing a spreadsheet.
2. Lack of contact seniority
If your rep is only talking to an individual contributor but the deal requires a VP-level signature, the deal is at risk. High-value B2B sales almost always require "multi-threading," which means building relationships with multiple stakeholders. If the "Contact Role" field in HubSpot is empty or only lists junior staff, the deal lacks the internal champion it needs to cross the finish line.
3. Decreasing engagement frequency
A sudden drop in email replies or meeting attendance is a classic sign of "ghosting." As HubSpot's 2026 guide on at-risk triggers points out, if a prospect has not replied for more than 7 days, the deal should be flagged. Healthy deals maintain a steady or increasing "pulse" of activity as they get closer to the close date.
4. Frequent close date pushes
When a sales rep moves the "Close Date" property in HubSpot for the third time in a month, it is rarely a good sign. While some delays are legitimate, frequent pushes often indicate that the rep is "happy-earing" the prospect. They are hearing what they want to hear instead of asking the hard questions about the buyer's timeline and budget.
5. Deal size significantly above average
It is tempting to get excited about a deal that is five times larger than your average sale. However, "whale" deals follow different rules. They have longer sales cycles and require more scrutiny. If a massive deal is moving through your pipeline at the same speed as a small one, it is likely that the rep hasn't fully qualified the requirements.
6. Missing key deal properties
AI models and sales managers both need data to make good decisions. If a deal is missing a "Budget," "Decision Maker," or "Pain Point" description, it is not a real deal yet. It is just a hope. Incomplete CRM data is one of the biggest contributors to inaccurate sales forecasts.
7. Negative sentiment in communications
Modern AI tools can now analyze the tone of emails and call transcripts. If the prospect's language shifts from "How do we implement this?" to "We are still reviewing our options," the health of the deal has changed. Identifying this shift in sentiment allows you to address concerns before they turn into a "Closed Lost" status.
How to monitor deal health at scale
Most sales managers try to monitor deal health by manually reviewing every record during weekly 1-on-1s. This does not work as your team grows. You cannot keep 100 deals in your head at once.
The limitations of manual CRM reviews
Manual reviews are biased. Reps are naturally optimistic and might downplay risks to keep their pipeline looking full. Managers also have limited time, so they often only look at the biggest deals, leaving smaller (but more winnable) opportunities to wither.
Using HubSpot reports to find stalled deals
You can build custom reports in HubSpot to track "Time in Stage" or "Last Activity Date." These are helpful, but they are "lagging" indicators. They tell you a deal has stalled, not that it is about to stall.
Why AI is better at spotting patterns
This is where AI-powered sales intelligence comes in. Instead of looking at one or two rules, AI looks at hundreds of data points simultaneously. It compares a current deal to thousands of past deals to see if the patterns match a "Win" or a "Loss."
Aigenture provides this intelligence directly inside your HubSpot CRM. It uses a machine learning model trained specifically on your company's historical data. This means the "Win Probability" score you see on a deal card is not a generic guess. It is a prediction based on how your customers actually buy.
Turning insights into action
Knowing a deal is at risk is only half the battle. You have to do something about it.
Coaching reps on at-risk deals
Use deal health signals as a coaching tool. Instead of asking "When will this close?", ask "I see the engagement frequency has dropped. What happened in the last meeting?" This helps the rep focus on the specific problem rather than just the outcome.
When to walk away from a "zombie" deal
Sometimes the best thing you can do for your revenue is to close a deal as "Lost." If a deal has been stalled for months and the health score is near zero, stop wasting time on it. Clearing the "zombie" deals out of your pipeline makes your forecast more accurate and frees up your team to find fresh opportunities.
Using Aigenture's deal health cards
Aigenture's native HubSpot cards show you exactly what is helping or hurting a deal. You might see an insight like "No contact with seniority in 14 days" or "Deal size is 40% above average for this stage." These plain-language insights allow you to take immediate action. You can jump on a call, bring in a senior executive, or ask the rep to re-qualify the budget.
By focusing on deal health instead of just deal stages, you can stop reacting to losses and start preventing them.
Ready to see the health of your pipeline? View our plans to see how Aigenture can help you identify at-risk deals today.